18th Annual Mount Sinai Inflammatory Bowel Disease Consultant's Course: Clinical Update and Practical Strategies


18th Annual Mount Sinai Inflammatory Bowel Disease Consultant's Course: Clinical Update and Practical Strategies Banner

Add to Calendar 18th Annual Mount Sinai Inflammatory Bowel Disease Consultant's Course: Clinical Update and Practical Strategies 11/20/2021 8:00:00 AM 11/20/2021 2:30:00 PM America/New_York For More Details: https://mssm.cloud-cme.com/course/courseoverview?EID=7687 Description: The 18th Annual Mount Sinai Inflammatory Bowel Disease Consultant's Course will provide an in-depth review of strategies for participants to better diagnose, classify and achieve remission in patients with Inflammatory Bowel Diseases. State-of-the-art lectures will be given by expert faculty on optimizing therapies, the treatment of fistula, epidemiology of IBD and challenging clinical scenarios such as ... Virtual false MM/DD/YYYY


Date & Location
Saturday, November 20, 2021, 8:00 AM - 2:30 PM, Virtual

Target Audience
Specialties - Gastroenterology, General Practice, Internal Medicine, Physician Assistant, Primary Care Physician, Surgeon

Course Overview
The 18th Annual Mount Sinai Inflammatory Bowel Disease Consultant's Course will provide an in-depth review of strategies for participants to better diagnose, classify and achieve remission in patients with Inflammatory Bowel Diseases. State-of-the-art lectures will be given by expert faculty on optimizing therapies, the treatment of fistula, epidemiology of IBD and challenging clinical scenarios such as cancer prevention in colitis, IBD in pregnant and nursing mothers. This year’s course will focus on the practical management of IBD.

Objectives
At the conclusion of this activity, the participant should be able to:

  1. Describe the use and adverse events associated with ozanimod, risankizumab, and upadacitinib.
  2. Describe treatment options for special populations including pregnant patients, patients with joint related complications, and patients with penetrating sequalae.
  3. Describe the evidence for diet based interventions in the management of inflammatory bowel disease.
  4. Describe appropriate implementation of therapeutic drug monitoring and treat-to-target approaches in clinical practice.
  5. Identify the rationale for positioning of biologic therapies for Crohn’s disease and ulcerative colitis.

Registration

Registration is complimentary 

Cancellation Policy
All cancellation requests must be emailed to the CME office at [email protected] by November 15, 2021.


Accreditation
The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credits
AMA PRA Category 1 Credits™ (5.50 hours), Non-Physician Attendance (5.50 hours)

Keywords: LIVE